Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
7.48
-0.18 (-2.35%)
At close: Oct 13, 2026, 4:00 PM EDT
7.47
-0.01 (-0.13%)
After-hours: Oct 13, 2026, 6:29 PM EDT
Precigen Market Cap
Precigen has a market cap or net worth of $2.68 billion as of October 13, 2026. It is the 5,505th most valuable company in the world and the 1,563rd biggest in the United States. Its market cap has increased by 188.06% in one year.
Market Cap
2.68B
Enterprise Value
2.74B
1-Year Change
188.06%
Global Rank
Country Rank
#1,563 United States
Category
ChartMarket Cap Chart
Since August 8, 2013, Precigen's market cap has increased from $2.32B to $2.68B, an increase of 15.43%. That is a compound annual growth rate of 1.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 2.68B | 81.08% |
| Dec 31, 2025 | 1.48B | 350.91% |
| Dec 31, 2024 | 328.00M | -1.68% |
| Dec 29, 2023 | 333.60M | 5.44% |
| Dec 30, 2022 | 316.40M | -58.75% |
| Dec 31, 2021 | 767.00M | -59.45% |
| Dec 31, 2020 | 1.89B | 112.19% |
| Dec 31, 2019 | 891.50M | -0.66% |
| Dec 31, 2018 | 897.40M | -35.47% |
| Dec 29, 2017 | 1.39B | -51.74% |
| Dec 30, 2016 | 2.88B | -17.89% |
| Dec 31, 2015 | 3.51B | 26.82% |
| Dec 31, 2014 | 2.77B | 19.88% |
| Dec 31, 2013 | 2.31B | -0.51% |
| Aug 8, 2013 | 2.32B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 3.21B |
| Denali Therapeutics | 3.11B |
| Arcus Biosciences | 3.11B |
| Dyne Therapeutics | 3.11B |
| Enliven Therapeutics | 3.00B |
| Zai Lab | 2.81B |
| NewAmsterdam Pharma Company | 2.58B |
| Beam Therapeutics | 2.57B |